Compliance with secondary prevention of ischemic stroke a prospective evaluation

Stroke

Volumn 32, Issue 8, 2001, Pages 1884-1889

  Sappok, Tanja ^a   Faulstich, Andreas ^a   Stuckert, Erika ^a   Kruck, Holger ^a   Marx, Peter ^a   Koennecke, Hans Christian ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Königin Elisabeth Herzberge Hospital   (Germany)

Author keywords

Antithrombotic therapy; Medical management; Prevention; Stroke, ischemic

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; PHENPROCOUMON; PYRIDINE DERIVATIVE; TICLOPIDINE;

ADOLESCENT; ADULT; AGE; ANTICOAGULATION; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; EMBOLISM; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION;

EID: 0034892744     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.8.1884     Document Type: Article

References (30)

1. Mortality by cause for eight regions of the world: Global Burden of Disease Study
2. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
3. Antithrombotic and thrombolytic therapy for ischemic stroke
4. Stroke prevention by the practitioner
5. Risk factors and their management for stroke prevention: Outlook for 1999 and beyond
6. Effect of antihypertensive treatment in patients having already suffered from stroke
7. Case-control study of stroke and the quality of hypertension control in North West England
8. Epidemiology Survey: Post-Stroke Antihypertensive Treatment Study: A preliminary result
9. Smoking cessation and the risk of stroke in middle-aged men
10. Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
11. Recommendations on stroke prevention, diagnosis, and therapy
12. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
13. Antiplatelet therapy: Views from the experts
14. Long-term prognosis of cerebral ischemia in young adults
15. Antithrombotic and antihypertensive management 3 months after ischemic stroke
16. Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe
17. Stroke risk management
18. Computed tomographic brain scans and antiplatelet therapy after stroke: A study of the quality of care in Dutch hospitals
19. Atrial fibrillation and stroke prevention in the community
20. Stroke and atrial fibrillation: Is stroke prevention treatment appropriate beforehand?
21. Warfarin use among patients with atrial fibrillation
22. Preventive care for patients following myocardial infarction
23. Risk factor modification in stroke prevention: The experience of a stroke clinic
24. Modification of risk factors after cerebral infarct: Results of the Klosterneuburg Stroke Databank
25. Predicting survival for 1 year among different subtypes of stroke
26. Risk factors for early recurrence after ischemic stroke
27. Identification and management of stroke risk in older people: A national survey of current practice in primary care
28. Warfarin for atrial fibrillation
29. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly
30. Health-related quality of life among long-term survivors of stroke: Results from the Auckland Stroke Study, 1991-1992